Key facts
- Notable investors include Bosch Ventures, LBBW Venture Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Applyo Jena
- ·The full record, as it builds
Funding rounds
No funding rounds for Applyo Jena are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Applyo Jena
Manufacturer of molecular biology reagent mixtures intended to stabilize sensitive biochemical and molecular reagents for applications in diagnostics and research. The company offers custom formulation development, lyophilization contract manufacturing, analytical quality control, product development support, validation and verification services, and handling and packaging systems, enabling clients to eliminate the need for cold-chain logistics and extend product shelf life for point-of-care testing.
- Sector
- Healthcare
- HQ
- Jena, Germany
- Founded
- 2021
- Employees
- 13
- Website
- applyo-jena.com/
- Ownership
- Privately Held (backing)
Applyo Jena doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Applyo Jena shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Applyo Jena in its N-PORT filings yet. We sweep new filings monthly.